New Key Statistics Module, Z-Score and F-Score
OTCPK:ACORQ Key Ratios
| Market Cap $ M | 0.02 |
| Enterprise Value $ M | 39.08 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | -- |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 72.00 |
| EPS (TTM) $ | -186.72 |
| Beneish M-Score | -3.35 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -1,054.10 |
| EV-to-EBIT | -0.15 |
| EV-to-EBITDA | -0.16 |
| PEG | -- |
| Shares Outstanding M | 1.24 |
| Net Margin (%) | -320.09 |
| Operating Margin % | -7.72 |
| Pre-tax Margin (%) | -374.15 |
| Quick Ratio | 1.79 |
| Current Ratio | 1.82 |
| ROA % (ttm) | -78.69 |
| ROE % (ttm) | -1,800.75 |
| ROIC % (ttm) | -1.52 |
| Dividend Yield % | -- |
| Altman Z-Score | -33.04 |
ACORQ Number of Guru Trades
ACORQ Volume of Guru Trades
Gurus Latest Trades with OTCPK:ACORQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:ACORQ is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Acorda Therapeutics Inc Insider Transactions
No Available Data
News about OTCPK:ACORQ
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers